Alissa Wong MSPH

Alissa Wong is a Policy Analyst, Assistant on the Biomedical Innovation team at Duke-Margolis, and her work focuses on initiatives under cooperative agreements with the U.S. Food and Drug Administration and the Institute’s Real-World Evidence Collaborative. Prior to Duke-Margolis, Alissa was Program Coordinator at the Patient-Centered Outcomes Research Institute (PCORI) and a Postgraduate Associate at the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency. Her past research has focused on regulatory science, emerging therapeutics, and health care worker wellbeing.